NCT05875805Recruiting
A Telehealth Advance Care Planning Intervention
A Telehealth Advance Care Planning Intervention for Older Patients With Myeloid Malignancies: A Pilot Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 11 Sept 2026
Brief summary (registry, in English)
The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 207 (estimated)
- First submitted
- 16 May 2023
- Start date
- 20 May 2024
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- University of Rochester
- NCT number
- NCT05875805
What you commit to
- Study type: Interventional
- Planned participants: 207
- From 20 May 2024 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- None
- Inclusion and Exclusion Criteria for Caregivers
- \- None
- Inclusion and Exclusion Criteria for Oncology Providers
- \- None
Who the study is looking for
- Age ≥60 years
- A diagnosis of AML, MDS, and similar myeloid malignancies (including but not limited to MDS/MPN overlap syndrome, myelofibrosis)
- Being managed in the outpatient settings
- Able to provide informed consent
- English-speaking
- Age ≥18 years
- Selected by patient when asked if there is a "family member, partner, friend, or caregiver with whom you discuss or who can be helpful in health-related matters"
- Able to provide informed consent
- English-speaking
- \- Oncologists and/or APPs who will be conducting the telehealth-delivered ACP visit
Criteria the registry did not label
- Inclusion and Exclusion Criteria for Patients
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Rochester Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.